Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

71%

5 trials in Phase 3/4

Results Transparency

14%

1 of 7 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 3

4(57.1%)

Phase 2

2(28.6%)

Phase 4

1(14.3%)

7Total

Phase 3(4)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT01037816Phase 4Completed

FS-67 in the Treatment of Pediatric Patients With Ankle Sprain

Role: lead

NCT01400594Phase 2Completed

Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

Role: lead

NCT00647231Phase 2Completed

HKT-500-US12 In Adult Patients With OA Knee Pain

Role: lead

NCT00792727Phase 3Completed

HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain

Role: lead

NCT00927641Phase 3Completed

HKT-500 in the Treatment of Adult Patients With Ankle Sprain

Role: lead

NCT00680784Phase 3Completed

HKT-500 in Adult Patients With Ankle Sprain

Role: lead

NCT00680472Phase 3Completed

HKT-500 in Adult Patients With Shoulder Pain

Role: lead

All 7 trials loaded